InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Benatti Luca, Director. Officer active across 1 company, notably Intercept Pharmaceuticals, INC.. Aggregated, 5 disclosures have been published. Activity tracked since 27 May 2021. The latest transaction was disclosed on 8 November 2023 (U). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
25,487 shares@ US$19.00100.0% of flowCommon StockSEC:0001104659-23-117110:0
8,111 shares0Common StockSEC:0001104659-23-064846:0
7,737 shares0Common StockSEC:0001104659-22-065918:0
7,029 shares0Common StockSEC:0001104659-21-075215:0
7,029 shares0Common StockSEC:0001104659-21-075215
5 of 5 declarations
About Benatti Luca
Luca Benatti is a Director at INTERCEPT PHARMACEUTICALS, INC. In this role, he participates in the governance and strategy of the company. INTERCEPT PHARMACEUTICALS, INC. is a biopharmaceutical company specializing in developing treatments for liver diseases. Luca Benatti brings his expertise in health to help guide strategic decisions.
